Viral Profiling Identifies Multiple Subtypes of Kaposi’s Sarcoma
ABSTRACT Kaposi’s sarcoma (KS), caused by KS-associated herpesvirus (KSHV), is the most common cancer among HIV-infected patients in Malawi and in the United States today. In Malawi, KSHV is endemic. We conducted a cross-sectional study of patients with HIV infection and KS with no history of chemo-...
Guardado en:
Autores principales: | Mina C. Hosseinipour, Kristen M. Sweet, Jie Xiong, Dan Namarika, Albert Mwafongo, Michael Nyirenda, Loreen Chiwoko, Deborah Kamwendo, Irving Hoffman, Jeannette Lee, Sam Phiri, Wolfgang Vahrson, Blossom Damania, Dirk P. Dittmer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2552bd5127547a58badd56978889fa5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration
por: Louise Giffin, et al.
Publicado: (2015) -
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.
por: Andrea J O'Hara, et al.
Publicado: (2009) -
RIG-I Detects Kaposi’s Sarcoma-Associated Herpesvirus Transcripts in a RNA Polymerase III-Independent Manner
por: Yugen Zhang, et al.
Publicado: (2018) -
Kaposi’s Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes
por: Kurtis M. Host, et al.
Publicado: (2017) -
Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins.
por: Wuguo Chen, et al.
Publicado: (2012)